Lung adenocarcinoma
Conditions
Interventions
Sponsors
First Affiliated Hospital of Kunming Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients whose diagnosis of lung adenocarcinoma has been confirmed by pathology; 2. Age >= 18 years old, gender not restricted; 3. Have undergone surgical treatment and can obtain sufficient cancer tissue and corresponding adjacent tissue samples; 4. The subjects or their legal representatives have given informed consent and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients who received chemotherapy, radiotherapy, or immunotherapy before surgery; 2.Patients with a history of other malignant tumors; 3.Patients with severe immune system diseases, chronic wasting diseases, or genetic disorders; 4.Pregnant or breastfeeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expression levels of CFB and FOS in tumor and adjacent tissues; | — |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of CD4+FoxP3+ regulatory T cells in tumor tissues;Tryptophan metabolism-related gene expression and kynurenine levels; | — |
Countries
China
Contacts
Public ContactChenglu He
The First Affiliated Hospital of Kunming Medical University
Outcome results
None listed